Video Feedback Intervention for Cognitively Impaired Older Drivers

NCT ID: NCT02600026

Last Updated: 2018-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will use an in-car monitoring system supplemented with video feedback to reduce the number of unsafe driving behaviors. If successful, this technology will provide a means to enhance public safety on the roads that could be adopted immediately in this at-risk group of drivers. The intervention will also maximize the time for independent driving, improving the overall quality of life of these individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goals of this clinical trial are to 1) document real-time impaired driving behaviors, and 2) reduce their occurrence, to improve the safety of cognitively impaired elders who continue to drive. This will be accomplished by placing small digital video event recording devices in the vehicles of 60 older cognitively impaired drivers. A 3-month baseline will establish the frequency of unsafe driving events, followed by a 3-month video feedback intervention during which the driver and family member will review the video recorded errors on a weekly basis. Active treatment will be compared to video monitoring with no feedback. A 6-month post-intervention phase will establish sustainability of the treatment.

The results of this clinical trial will confirm the potential to improve driving safety among older drivers with cognitive impairment using a behavior modification approach aimed directly at the problem behaviors observed in their natural driving environment. Knowledge gained about the magnitude and duration of the treatment effect and the potential of using an internet based feedback program will provide the impetus to optimize and ultimately implement the intervention to improve the safety of older drivers with mild cognitive impairment and early AD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Impaired Driving

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video Camera: Intervention

DriveCam video event recorder with feedback

Group Type EXPERIMENTAL

DriveCam

Intervention Type DEVICE

Video event monitoring device

Feedback

Intervention Type BEHAVIORAL

Video feedback intervention

Video Camera: Monitoring

DriveCam video event recorder with no feedback

Group Type PLACEBO_COMPARATOR

DriveCam

Intervention Type DEVICE

Video event monitoring device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DriveCam

Video event monitoring device

Intervention Type DEVICE

Feedback

Video feedback intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 50-90
* will be categorized as CDR= 0.5, or 1
* English speaking
* currently driving adults
* have a valid driving license
* have at least 10 years of driving experience
* have a MMSE \< 28
* have an adult family member or other caregiver, age \>21, to participate in video feedback

Exclusion Criteria

* ophthalmologic, physical, or neurologic disorders other than dementia that impair their driving abilities
* visual acuity worse than 20/40 in best eye using distance vision measured by wall chart
* homonymous hemianopia or bitemporal hemianopia
* musculoskeletal disorders causing major physical handicaps
* history of alcohol or substance abuse by DSM V criteria within the past year
* sedating medications that impair level of consciousness or attention
* language impairment that would interfere with the ability to participate in the educational intervention
* previous road test evaluation or opinion of caregiver or health professional that participant is unsafe to drive.
Minimum Eligible Age

50 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alzheimer's Association

OTHER

Sponsor Role collaborator

Rhode Island Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brian Ott

Brian R. Ott, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian Ott, MD

Role: PRINCIPAL_INVESTIGATOR

Rhode Island Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rhode Island Hospital

Providence, Rhode Island, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gauri Vasudevan, B.S.

Role: CONTACT

401-444-7111

Memory Center

Role: CONTACT

1-844-5MEMORY

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gauri Vasudevan

Role: primary

401-444-7111

Memory Center

Role: backup

1-844-5MEMORY

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

799824-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neurofeedback in Alzheimer's Disease
NCT03790774 TERMINATED NA
Neurofeedback to Aid Vets' Memory
NCT04446481 COMPLETED NA
Gerofit and Cognition
NCT06107842 RECRUITING NA